About half of all patients who start medication-assisted treatment will leave care within six months. That is not a patient failure. It is a sign that the system around them needs work. MAT patient retention is one of the clearest measures of whether opioid use disorder treatment is working at all.
The stakes could not be higher. Every patient who leaves early faces a sharp rise in overdose risk. The first four weeks after someone stops their medication are the most dangerous. That is why keeping patients in MAT is a public health priority, not just a clinic metric on a dashboard.
Retention problems rarely have a single cause. Side effects during induction and stabilization push some people away early.
Others leave because of stigma, cost, travel, or life events like a job change or a move. Many drop out quietly — missing one visit, then another, until the chart simply closes.
This guide is built for MAT clinic directors, OTP leaders, and clinical operations staff. You will learn what current data says about retention. You will also see why patients truly leave, and how top-performing clinics respond.
Tools like Curogram's Opus EHR integration help teams spot risk signals and act fast. But the core work stays human.
We will cover the benchmarks you should measure against. Then we will walk through five honest reasons patients drop out.
After that, we will share what a retention-focused clinic looks like, plus seven strategies that move the needle. You will also learn how to measure retention the right way. Small process changes add up to lives saved.
Before you can fix a retention problem, you need to know what normal looks like. Public data from SAMHSA and NIDA paints a sobering picture. Most MAT programs lose a large share of patients in the first six months.
Buprenorphine retention rates and methadone treatment retention tell slightly different stories. Understanding these benchmarks helps clinics set honest goals — and spot where they are falling short.
Retention at 6 and 12 months is the gold-standard measure for MAT. SAMHSA and NIDA estimate that 40–60% of patients stay in care at 6 months. By 12 months, that number often drops to 30–50%. The swing depends on the medication, the setting, and the support around the patient.
Here is a simple view of the public benchmarks:
|
Time in Care |
Buprenorphine |
Methadone |
Extended-Release Naltrexone |
|
3 months |
65–80% |
75–85% |
50–65% |
|
6 months |
50–60% |
60–70% |
30–45% |
|
12 months |
35–50% |
50–60% |
20–35% |
Ranges based on public SAMHSA and NIDA benchmarks; exact figures vary by study.
These numbers look low at first glance. But they matter because each percentage point represents real people. A clinic with 300 patients that improves 6-month retention from 50% to 60% keeps 30 more patients in care.
That is 30 fewer people at high risk of overdose, arrest, or hospital admission. Small gains in keeping patients in MAT add up fast.
Retention is not the same across every medication or every clinic setup. Methadone, delivered through opioid treatment programs, tends to show the highest retention rates.
Daily dosing and on-site support create strong routines. Buprenorphine, often prescribed in office-based settings, offers more flexibility but can see more drop-off without the right structure.
Naltrexone has the lowest retention of the three. It requires full detox before the first dose, which is a steep hurdle. Suboxone adherence in outpatient care depends heavily on follow-up and easy access to refills. Patients who hit a pharmacy wall or wait weeks for a follow-up visit often fall out of care.
Setting matters as much as medication. Rural clinics face transportation gaps that hurt retention. Urban OBOT practices may see higher early dropout but better long-term retention if they offer telehealth. Harm reduction programs that meet patients without strict rules often hold people in care longer.
The lesson is clear. Benchmarks are a starting point, not a verdict. Your own numbers should be read against the medication you offer and the community you serve.
A 45% 6-month retention rate for buprenorphine in a rural area may be strong. The same number in a well-resourced urban OBOT practice would be a warning sign worth acting on.
Most MAT dropout does not come from one big event. It builds from many small frictions that stack up until the patient gives up.
These pressures hit early in care, during induction and stabilization, and again during long-term recovery. Knowing the top five patterns helps clinic teams design better support. Each reason below calls for a different fix.
The first two weeks of MAT are often the hardest. Patients starting buprenorphine may feel nauseous, tired, or anxious. Some worry they are trading one dependence for another. Others fear precipitated withdrawal, especially when moving from full agonists to buprenorphine.
These early days shape everything. If a patient has a rough first week and cannot reach the clinic easily, they may stop on their own. If they stop, the odds of relapse climb sharply. That is why rapid support during induction and stabilization is so important.
Clinics that retain patients here do three things well:
They explain side effects before they happen, so patients are not caught off guard.
They offer a same-day or next-day contact option for questions.
They follow up in the first 72 hours to check in, adjust expectations, and offer reassurance.
Text-based check-ins work especially well for this, because they are low effort for both sides.
Fear is a bigger driver than many clinics realize. Patients hear stories from friends or social media. They wonder if they will feel like themselves again. A brief, honest conversation about what to expect — written in plain language — can cut early dropout in a meaningful way.
Stigma is still one of the most common reasons patients leave MAT. People in recovery often hear that they are "not really sober" if they take medication. This message can come from family, sponsors, employers, or even other health providers. Over time, the weight of it pushes people to stop their medication to prove a point.
Clinic stigma hurts even more. If front desk staff seem judgmental, patients notice. If a provider uses loaded words like "addict" or "clean" in a clinical note, trust erodes. Person-first language matters. So does training everyone who touches the patient, from receptionists to billing.
Internal stigma also plays a role. Patients may feel shame about their history or their current use. They may hide a lapse instead of bringing it to the clinic. When they expect punishment, they stay silent. When they expect compassion, they come back.
Clinics can push back on stigma in simple ways. Post welcoming signage that names MAT as evidence-based care.
Train staff on respectful communication every six months. Share patient stories (with consent) that normalize long-term recovery on medication. These moves build a setting where people want to stay.
Access barriers quietly end more MAT episodes than any clinical issue. A patient who cannot get a ride to the clinic every week will eventually stop coming.
A patient who cannot afford a co-pay will skip refills. A pharmacy that refuses to stock buprenorphine — or gives patients a hard time — adds one more reason to quit.
Transportation is the most common barrier in both rural and urban settings. Long bus rides eat into work hours. Gas money runs out before the next visit. Telehealth maintenance visits remove much of this friction, but not all clinics use them.
Cost is the second big driver of MAT dropout. Even with insurance, surprise bills and prior auth delays can halt a patient's treatment. Some patients stretch doses or skip doses to make a script last longer. Clinics that help with financial assistance forms keep more patients in care.
Pharmacy friction is the third piece. Patients report being looked at sideways when they present a buprenorphine script. Some pharmacies run out of stock with no notice. Building relationships with two or three reliable local pharmacies protects patients from this gap.
Life rarely stands still during recovery. Patients may lose housing, change jobs, or move cities during treatment. Any of these shifts can disrupt care in ways that are not the patient's fault. A new work schedule may clash with clinic hours. A move across town may place the clinic out of reach.
Relapse is part of opioid use disorder treatment for many patients. It is a symptom of the disease, not a sign of failure. Clinics that treat relapse as a clinical event — not a rule break — keep more people in care. Discharging a patient after a relapse often pushes them to higher-risk use, not abstinence.
Employment changes deserve special attention. A new job may mean new hours, new insurance, or a fear that MAT will be discovered. Patients may skip visits to avoid time off work. Flexible scheduling and telehealth visits help here.
Housing instability is the hardest life transition to support. Patients without stable housing may lose their phone, their medication, or their ID.
Partnering with local harm reduction groups and housing services creates a safety net. When patients know they can come back after any life disruption, they do.
Not every reason for dropout sits with the patient. Some live inside the clinic's own workflows. A three-week wait for induction sends patients back to the street.
A missed-appointment policy that locks people out after two no-shows drives dropout. A phone tree that does not route to a real human keeps people from asking for help.
Front desk culture matters as much as clinical protocols. If patients feel rushed, watched, or judged at check-in, they stop coming. If the only communication channel is a phone call during work hours, many will miss messages. Every extra step between the patient and care is a chance to lose them.
Billing and paperwork also quietly push people out. Long intake forms at every visit, repeated insurance checks, or unclear co-pay requests all add friction. Each one is a reason to skip the next appointment.
The fix is to audit the patient's path end to end. Time how long intake takes. Count how many steps stand between a patient and a refill. Ask recently re-engaged patients what almost kept them away. Small changes — like a two-way text channel or a streamlined intake — often produce big retention gains.
A clinic that keeps patients in MAT does not rely on luck. It is built around how real patients actually live and how the disease actually behaves.
The best practices share four habits: fast access, steady contact, quick follow-up on missed visits, and tight outside partnerships. None of these require huge budgets. They require clear workflows and the right tools to run them.
The first pillar of retention is removing friction from scheduling. Patients who wait two or three weeks to start treatment often never start at all. Clinics that offer same-day or next-day induction see much higher early retention. Once a patient decides to seek help, the window is short.
Online self-scheduling is a simple lever. It lets patients book at 2 a.m. when they are ready to reach out. Two-way texting lets them confirm, reschedule, or ask a quick question without a phone call. Both reduce the barrier between intent and action.
Short visit lengths also help. A 15-minute maintenance check fits into a lunch break. A 60-minute visit does not. Clinics that offer flexible visit lengths — short when possible, longer when needed — match the pace of real life.
The measure of success is simple. Count the days between first contact and first dose. Then count the no-show rate on induction visits. Both numbers will drop when scheduling becomes patient-centered.
Between-visit contact keeps patients anchored. A short text three days after induction asks, "How are you feeling? Any side effects we should know about?" That one message catches problems early. It also tells the patient the clinic cares.
Text check-ins scale in a way that phone calls never will. A staff member can send templated messages to a full panel in an hour. Replies surface the patients who need attention that day. This pattern turns a small team into a responsive one.
HIPAA rules matter here. Standard SMS is fine for generic check-ins and appointment reminders. Anything involving clinical details, test results, or specific treatment information belongs inside a secure channel. Curogram client data from clinical settings shows that automated appointment reminders can cut no-show rates well below the industry average.
Cadence also matters. Daily texts feel intrusive. Weekly or bi-weekly pulses feel supportive. Tie the frequency to the phase of care — more contact during induction and stabilization, less during steady long-term recovery.
A missed appointment is the single most important event to act on in MAT. The first 48 hours are the window. After that, the chances of re-engagement drop sharply. Clinics that reach out the same day keep more patients in care.
Structured outreach beats ad hoc calling. A workflow that triggers a text within hours, a call within one day, and a portal message within two days covers most patients. The message tone should be warm, not shaming. "We noticed you missed today — is there anything we can help with?" works far better than "You failed to show."
Curogram client data from clinical settings shows that SMS recalls can bring a meaningful share of overdue patients back. In one multi-specialty case, 35% of patients who received an SMS recall booked an appointment within a month, and 1,240 patients returned from recall messages alone.
That example is not MAT-specific, but the pattern of SMS-driven re-engagement applies directly to MAT workflows.
No MAT clinic stands alone. The pharmacy is the last mile between the clinic and the patient. A pharmacy that stocks buprenorphine reliably, treats patients with respect, and flags issues early is a true partner. Building a short list of preferred pharmacies protects patients from friction.
Harm reduction services are the safety net. Syringe exchanges, naloxone distribution, and street outreach teams often see patients before or after the clinic does. Strong ties to these groups mean patients who drop out of formal care still get life-saving support.
Care coordination also includes primary care, mental health, and social services. A patient with untreated depression or unstable housing will struggle to maintain suboxone adherence. Clinics that make warm handoffs — not just referral faxes — see better long-term outcomes.
The simplest measure of good coordination is this: can a patient reach the right person in under 15 minutes when they need help? If the answer is yes, most of the work is done.
The four habits above describe the shape of a retention-focused clinic. Below are seven concrete strategies that bring those habits to life. Each one is tested in real-world MAT settings. Start with the one that matches your biggest drop-off point. Then layer in the rest.
Patients seeking MAT are often at their most ready when they first call. Waiting two weeks for an induction slot loses many of them. Same-day access is the single strongest lever for early retention. It turns intent into action while the window is still open.
Same-day access does not require a massive staffing model. Many clinics reserve two or three slots each day for walk-ins or same-day calls. Others use a warm-handoff system with a partner clinic for overflow.
The impact shows up in three places. Induction no-show rates drop because there is less time for doubts to creep in. Early retention at 30 days climbs. And the community gains trust — word spreads fast when a clinic says yes on the first try.
Track two numbers to measure this. Time from first call to first dose, and induction no-show rate. Both should trend down within a few months of launching same-day access.
Once a patient is stable, most maintenance visits can happen over video. Telehealth removes the travel burden that drives so much dropout. It fits into work breaks, childcare windows, and early mornings. Patients who would miss an in-person visit will often show up for a 15-minute video call.
Regulations now allow buprenorphine prescribing via telehealth in many settings. Methadone rules are tighter but have loosened for stable patients. Check your state rules before rolling out.
Telehealth also expands reach. Patients in rural areas who once drove two hours now connect from home. Patients with mobility or anxiety barriers participate more fully. The bar to showing up drops.
Do not make telehealth the only option. Some patients prefer in-person visits. Some clinical moments require them. The best practice is a hybrid model — in-person for induction and stabilization, video for steady maintenance, with the patient able to choose either for most visits.
Generic reminders do not fit MAT. MAT visit cadence is tighter and more variable than most specialties. A patient may need weekly visits during induction and stabilization, then monthly in maintenance. Reminder systems must flex with this rhythm.
Tune reminders to three windows: three days out, one day out, and two hours out. The three-day message gives time to reschedule if needed. The one-day message confirms intent. The two-hour message catches day-of drift.
Message tone should stay warm and simple. "Hi Maria, we're looking forward to seeing you tomorrow at 10 a.m. Reply YES to confirm or call us to move the time." That is plain, respectful, and easy to act on.
Curogram client data from clinical settings shows that automated reminders cut no-show rates to 53% below the industry average. In MAT specifically, that kind of gain translates to more patients staying on medication and fewer dangerous gaps in care. Reminder systems are one of the highest-return investments a clinic can make.
Every missed MAT visit should trigger a defined workflow. The first contact should happen within hours, not days. The second and third should follow a clear schedule. The message should stay supportive, never punitive.
A practical cadence looks like this:
Each step lowers the risk that a missed visit becomes a closed chart. Clinics that skip this workflow lose patients to silence.
Outreach tone matters as much as outreach speed. Patients who expect a lecture will avoid the call. Patients who expect help will pick up. Train staff to open every outreach with care, not correction.
Measure two things. The percentage of missed-visit patients who reschedule within seven days, and the 30-day retention of those who do. Both should climb as the workflow matures.
Peer-support specialists — people in long-term recovery themselves — change outcomes in MAT. They speak the language of lived experience. They can say what a clinician cannot. Patients often trust them first, and that trust opens the door to staying in care.
Peer workers can ride along on intake calls, lead group sessions, and follow up with patients who go quiet. They help with harm reduction conversations and relapse planning. They also model that long-term recovery on medication is real and possible.
Integration is the key word. Peer specialists work best when they are part of the team, not an add-on. That means shared notes, shared huddles, and a clear scope of practice. It also means fair pay and training.
Clinics without in-house peer staff can partner with local recovery community organizations. A referral relationship is better than nothing. The goal is to put a peer voice in reach of every patient at every stage of their care.
Many MAT patients hold jobs with rigid schedules. A 9-to-5 clinic does not match a 6 a.m. construction shift. If the only option is missing work to make an appointment, most patients will miss the appointment instead.
Flexible scheduling solves this. Early-morning slots before 8 a.m. catch shift workers. Evening hours after 5 p.m. catch office workers. Saturday morning clinics serve people who cannot get time off.
Telehealth maintenance visits add another layer of flexibility. A 15-minute video call at 7 a.m. is feasible for almost any patient. In-person visits for labs or required checks can be scheduled less often.
The operational lift is real but manageable. Many clinics start with one extended-hours day per week and grow from there. Staff rotations and part-time clinicians can cover the expanded window. The return shows up in improved retention and fewer missed visits.
Most patients in MAT have a history of trauma. Punitive policies — strict no-show rules, positive-test discharges, contract-style agreements — often recreate the feelings that led to use in the first place. A trauma-informed approach changes the tone of every interaction.
Start with language. Use "return to use" instead of "dirty test." Use "missed visit" instead of "failure to show." Frame relapse as a clinical symptom, not a rule break. Small word changes shift the whole clinic's culture.
Policy choices matter too. Review discharge criteria and ask whether they actually serve the patient. Consider whether missed visits should trigger outreach instead of dismissal. Ask whether a positive test is a reason to escalate care, not end it.
Staff training is the third piece. Every person who touches a patient — from the front desk to the medical director — should have basic trauma-informed training. This is not a one-time seminar. It is an ongoing practice that shows up in every call, every visit, and every note.
Measuring retention is harder than it looks. Different definitions produce very different numbers. A clinic may report 70% retention using one method and 40% using another — for the exact same patients. Picking the right measure matters for internal quality work and for any external reporting.
There are two common ways to measure MAT retention. The first tracks medication pickup from the pharmacy. The second tracks continuous engagement with the clinic through visits, check-ins, and contact. Both tell part of the story. Neither tells all of it.
Pharmacy pickup is easy to measure. You know if the script was filled, when, and for how many days. This method catches one important signal — whether the patient has medication on hand. But it misses the clinical side. A patient can fill refills while skipping visits. Eventually the relationship frays and the patient drops out.
Continuous engagement is harder to measure but more complete. It looks at whether the patient is still in active care — attending visits, responding to check-ins, and refilling medication. This view catches quiet dropout earlier. It also shows when a patient is at risk before they fall out of care.
The best practice is to track both. Pair pharmacy pickup data with visit and contact data. When the two diverge — refills filled but visits missed, or visits attended but refills lapsed — flag the patient for outreach. That crossover point is often the earliest warning sign of MAT dropout.
Tools that sit inside the EMR make this easier. A dashboard that pulls both refill and visit data in one view lets care teams act fast. Without that integration, the two data streams sit in separate systems, and patients slip through the gap.
The second measurement challenge is defining what counts as one treatment episode. If a patient misses two weeks and comes back, is that still the same episode?
What about two months? Different answers produce very different retention rates. A clinic with a loose definition will look better on paper than a clinic with a strict one.
SAMHSA and many research studies use a 14-day or 30-day gap rule. If the patient has no contact and no refill for that window, the episode is considered closed. A return to care starts a new episode. This definition aligns internal numbers with external benchmarks.
Some clinics use an even stricter rule for internal quality work. A seven-day gap counts as a break. This approach surfaces problems earlier. It also avoids the trap of letting quiet dropout inflate retention numbers.
The key is to pick a definition, document it, and use it consistently. A clinic that changes its definition between quarters cannot measure real progress. A clinic that publishes retention numbers without defining the episode rule is not being honest.
Also track re-engagement rates separately. How often does a patient return after a gap? How quickly?
These are powerful measures of system health — even more than pure retention. A clinic that loses patients but brings many of them back is doing real work. One that loses patients and never sees them again is not.
MAT patient retention is not a marketing metric. It is a life-and-death measure of whether your clinic is truly helping people. Every patient you keep in care is a patient who stays at lower risk of overdose, arrest, and death. Every patient you lose is one the system failed, not the other way around.
The work of keeping patients in MAT is made of small, repeatable actions. Fast induction access. Text-based check-ins. Rapid outreach after a missed visit. A warm welcome, every time, no matter how many times a patient has come and gone. None of this is flashy. All of it matters.
The technology piece is real but secondary. The right tools — from SMS reminders to EMR-integrated dashboards — make good workflows scalable. They free staff to focus on people, not paperwork. They help you spot risk signals early and act before a quiet dropout becomes a lost patient.
Conversations at NatCon 2026 made one thing clear. The clinics seeing the strongest retention outcomes are the ones that built systems around patients, not the other way around. That shift in design thinking is available to any program willing to do the work.
Start with one change this quarter. Audit your missed-appointment workflow. Add a same-day induction slot. Launch a three-day post-induction check-in text. Pick the lever that matches your biggest drop-off point, measure it, and build from there.
Stop losing MAT patients to missed visits and quiet dropout. Book a demo now to see how automated reminders, SMS recalls, and EMR-integrated workflows keep more patients in care.